{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:11:42Z","timestamp":1770811902536,"version":"3.50.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":2081,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1165\/rcmb.2020-0051ed","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T15:08:31Z","timestamp":1582902511000},"page":"674-675","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":2,"title":["<i>Pneumocystis<\/i>\n                    Pneumonia: Checkpoint Inhibition to the Rescue?"],"prefix":"10.1093","volume":"62","author":[{"given":"Julian","family":"Better","sequence":"first","affiliation":[{"name":"Universities of Giessen and Marburg Lung Center, member of the German Center for Lung Research (DZL) Justus-Liebig-University Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Matt","sequence":"additional","affiliation":[{"name":"Universities of Giessen and Marburg Lung Center, member of the German Center for Lung Research (DZL) Justus-Liebig-University Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"2026021100424009800_bib1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2026021100424009800_bib2","doi-asserted-by":"crossref","first-page":"59729","DOI":"10.18632\/oncotarget.19927","article-title":"Risk factors for mortality from Pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"2026021100424009800_bib3","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM199011223232103","article-title":"Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double-blind, placebo-controlled trial","volume":"323","author":"Gagnon","year":"1990","journal-title":"N Engl J Med"},{"key":"2026021100424009800_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/156800961506150805145120","article-title":"Immune checkpoint inhibitors for cancer therapy: clinical efficacy and safety","volume":"15","author":"Azoury","year":"2015","journal-title":"Curr Cancer Drug Targets"},{"key":"2026021100424009800_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"2026021100424009800_bib6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.molmed.2019.08.004","article-title":"Checkpoint inhibition and infectious diseases: a good thing?","volume":"25","author":"Abers","year":"2019","journal-title":"Trends Mol Med"},{"key":"2026021100424009800_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1165\/rcmb.2019-0234OC","article-title":"PD-1 deficiency promotes macrophage activation and T-helper cell type 1\/T-helper cell type 17 response in Pneumocystis pneumonia","volume":"62","author":"Zhang","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021100424009800_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/IAI.02686-14","article-title":"Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia","volume":"83","author":"Lei","year":"2015","journal-title":"Infect Immun"},{"key":"2026021100424009800_bib9","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20030932","article-title":"Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor","volume":"198","author":"Steele","year":"2003","journal-title":"J Exp Med"},{"key":"2026021100424009800_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1165\/rcmb.2009-0367OC","article-title":"Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia","volume":"44","author":"Lasbury","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021100424009800_bib11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2026021100424009800_bib12","doi-asserted-by":"crossref","first-page":"91894","DOI":"10.1172\/jci.insight.91894","article-title":"Murine models of Pneumocystis infection recapitulate human primary immune disorders","volume":"3","author":"Elsegeiny","year":"2018","journal-title":"JCI Insight"},{"key":"2026021100424009800_bib13","doi-asserted-by":"crossref","first-page":"6750861","DOI":"10.1155\/2019\/6750861","article-title":"IL-17 inversely correlated with IL-10 via the STAT3 gene in Pneumocystis-infected mice","volume":"2019","author":"Rong","year":"2019","journal-title":"Mediators Inflamm"},{"key":"2026021100424009800_bib14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","article-title":"Pembrolizumab treatment for progressive multifocal leukoencephalopathy","volume":"380","author":"Cortese","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021100424009800_bib15","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMe1904140","article-title":"Can immune checkpoint inhibitors keep JC virus in check?","volume":"380","author":"Koralnik","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021100424009800_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/SHK.0b013e3182168cce","article-title":"Dose-dependent effect of anti-CTLA-4 on survival in sepsis","volume":"36","author":"Inoue","year":"2011","journal-title":"Shock"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/62\/6\/674\/66763764\/ajrcmb_62_6_674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/62\/6\/674\/66763764\/ajrcmb_62_6_674.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:42:52Z","timestamp":1770788572000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/62\/6\/674\/8461382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,1]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2020-0051ed","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"2020-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}